Description
Fate Therapeutics is a clinical‑stage biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life‑threatening diseases.
Team Members
Christian Weyer
President and CEO
Dan Shoemaker
Chief Research Officer
Scott Wolchko
Chief Operating & Financial Officer
Moya Daniels
VP of Regulatory Affairs and Quality Assurance
Randall Moon
Co-founder, William and Marilyn Connor Chair and Founding Director of the Institute for Stem Cell and Regenerative Medicine at University of Washington and Howard Hughes Medical Institute Investigator
